ZENCORE NEWS & EVENTS

News & Events News & Events

Congratulations to Xingji Biology on the Approval of IND Application for XJ101 by NMPA

2023-07-18 Zencore News

Congratulations to Xingji Biology on the approval of their IND application for XJ101 by the Center for Drug Evaluation (CDE) of NMPA. Zencore Biologics has provided comprehensive CMC services for XJ101. Working with Xingji on this project has been an incredible experience, and we are excited about the prospect of continuing our partnership in the future.

640.png

More NewsMore News
Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth
2025-01-16

Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth

View details →
Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection
2024-12-31

Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection

View details →
Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA
2024-12-22

Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA

View details →